Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral Water
Hypernatremia
About this trial
This is an interventional treatment trial for Hypernatremia focused on measuring Hypernatremia, intravenous hypotonic solution, enteral water
Eligibility Criteria
Inclusion Criteria: Hospitalized patients with hypernatremia (serum sodium>145mEq/L). Exclusion Criteria: Age below 18 years Pregnant, on dialysis Unwilling to participate or without informed consent.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Intravenous hypotonic solution
Enteral water
In this group, the administration will be according to the presence of basal hyperglycemia on the day before the assignment (>180mg/dL). If hyperglycemia is present, it will be glucose solution 5% 500ml + injectable water 500ml intravenous every 8 hours for a total of 3,600ml daily. If there is no hyperglycemia, it will be 5% glucose solution 1,200ml every 8 hours for a total of 3,600ml per day.
This group will receive bottled water through the nasogastric or orogastric tube at a dose of 150 ml/hour for a total of 3,600 ml per day.